Lannett: Pricing Pressure Has ‘Intensified Beyond Historical Norms’

US-Based Firm ‘Not Sitting Back’ To Address Challenges

challenge
Lannett has major steps to make to return to growth • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Earnings

More from Business